Skip to main navigation
Skip to search
Skip to main content
Utrecht University Home
Help & FAQ
Home
Research output
Search by expertise, name or affiliation
Innovative drug monitoring of factor VIII and emicizumab in haemophilia A
Anouk Donners
UU BETA RESEARCH
University Medical Centre
Research output
:
Thesis
›
Doctoral thesis 2 (Research NOT UU / Graduation UU)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Innovative drug monitoring of factor VIII and emicizumab in haemophilia A'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinical Laboratory
12%
Coagulation Factor VIII
12%
Dosing Strategy
12%
Drug Concentration
12%
Drug Monitoring
100%
Emicizumab
100%
Factor VIII (FVIII)
75%
Hemophilia
100%
Innovative Drugs
100%
Mass Spectrometry
12%
Mass Spectrometry Analysis
25%
Mass Spectrometry Methods
25%
Minimal Effective Concentration
12%
Minimum Effective Concentration
12%
Recurrent Bleeding
12%
Six-step
12%
Two-mass
12%
Pharmacology, Toxicology and Pharmaceutical Science
Bleeding
12%
Blood Clotting Factor
12%
Blood Clotting Factor 8
100%
Drug Concentration
12%
Emicizumab
100%
Haemophilia A
100%
Therapeutic Drug Monitoring
100%
Immunology and Microbiology
Drug Concentration
12%
Emicizumab
100%
Factor VIII
100%
Mass Spectrometry
25%
Minimum Effective Concentration
25%